oncology APISintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Cabazitaxel Acetone Solvate is a crystalline pharmaceutical intermediate of the taxane class, synthesized via solvent-mediated crystallization to enhance stability. The molecular formula is <strong>C43H53NO14·C3H6O</strong>, with CAS No. <strong>209287-78-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Used as a key raw material for producing Cabazitaxel injection in metastatic castration-resistant prostate cancer.</li>
<li><strong>Formulation Development:</strong> Serves as a stable polymorph for bioequivalence studies and generic drug registration.</li>
<li><strong>API Supply Chain:</strong> Facilitates high-purity active pharmaceutical ingredient processing for global contract manufacturers.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store under controlled temperature (2-8°C) and low humidity to prevent solvate loss. Personnel must wear PPE during handling due to potential cytotoxicity; avoid direct inhalation or skin contact per GMP guidelines.</p>